AI assistant
Sending…
Emergent BioSolutions Inc. — Director's Dealing 2016
Mar 11, 2016
32870_dirs_2016-03-11_63482f77-db12-46fa-a33b-df27974930a0.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2016-03-09
Reporting Person: Havey Adam (EVP, Biodefense Divison)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2016-03-09 | Common Stock | F | 1061 | $34.60 | Disposed | 47774 | Direct |
| 2016-03-10 | Common Stock | F | 1480 | $34.38 | Disposed | 46294 | Direct |
Footnotes
F1: Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
More from Emergent BioSolutions Inc.
Earnings Release
2026
Apr 30
Declaration of Voting Results & Voting Rights Announcements
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Proxy Solicitation & Information Statement
2026
Mar 20
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Board/Management Information
2026
Mar 3